Literature DB >> 6702454

Deterioration in lung function after general anaesthesia in patients with cystic fibrosis.

V F Richardson, C F Robertson, A P Mowat, E R Howard, J F Price.   

Abstract

48 hours after oesophagoscopy and injection sclerotherapy of oesophageal varices under general anaesthesia, 11 studies of 6 children with cystic fibrosis and portal hypertension showed a significant deterioration in 4 tests of lung function. The largest falls were seen in Forced Expiration Volume in one second (p less than 0.01) and Forced Expiratory Flow between 25% and 75% of Vital Capacity (p less than 0.02). In 14 studies of 10 children with portal hypertension from other causes a significant fall occurred only in Peak Expiratory Flow Rate (p less than 0.01). The slight falls in Forced Expiratory Volume in one second and Forced Expiratory Flow between 25% and 75% of vital capacity were significantly smaller than those observed in the patients with cystic fibrosis (p less than 0.05; p less than 0.01).

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6702454     DOI: 10.1111/j.1651-2227.1984.tb09901.x

Source DB:  PubMed          Journal:  Acta Paediatr Scand        ISSN: 0001-656X


  5 in total

1.  Ursodeoxycholic acid dissolution of gallstones in cystic fibrosis.

Authors:  B Salh; J Howat; K Webb
Journal:  Thorax       Date:  1988-06       Impact factor: 9.139

2.  The need to avoid general anaesthesia in cystic fibrosis.

Authors:  J F Price
Journal:  J R Soc Med       Date:  1986       Impact factor: 5.344

Review 3.  Current clinical management of hepatic problems in cystic fibrosis.

Authors:  M S Tanner
Journal:  J R Soc Med       Date:  1986       Impact factor: 5.344

Review 4.  Nasal polyposis, opaque paranasal sinuses and usually normal hearing: the otorhinolaryngological features of cystic fibrosis.

Authors:  T J David
Journal:  J R Soc Med       Date:  1986       Impact factor: 5.344

5.  Liver cirrhosis in cystic fibrosis.

Authors:  M D Stringer; J F Price; A P Mowat; E R Howard
Journal:  Arch Dis Child       Date:  1993-09       Impact factor: 3.791

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.